Researchers have developed a new way to monitor brain blood flow during surgery. The method, called sinusoidal intensity modulation speckle imaging, or Simsi, uses the physics of dynamic light scattering to image blood flow noninvasively, across a wide field of view and without high-speed cameras.
Researchers have developed a new way to monitor brain blood flow during surgery.
(Source: The University of Texas at Austin)
Texas/USA – Tracking the brain’s blood flow during neurosurgery represents one of the most critical and challenging parts of the operation. A brief interruption can mean the difference between permanent damage and full recovery, but it’s difficult to track blood flow across the surgical field.
Researchers at The University of Texas at Austin have developed a new way to monitor blood flow with standard camera hardware. The method, called sinusoidal intensity modulation speckle imaging, or Simsi, uses the physics of dynamic light scattering to image blood flow noninvasively, across a wide field of view and without high-speed cameras.
“This has been a fundamental challenge in the field for a long time,” said Andrew Dunn, a professor in the Cockrell School of Engineering’s Department of Biomedical Engineering whose lab published the finding in the Proceedings of the National Academy of Sciences. “Simsi gives us a way to get quantitative, physically meaningful numbers from a technique that is already fast and practical enough to use in the clinic.”
In addition to neurosurgery, this technology could improve monitoring during cardiac surgery, help assess tissue viability in reconstructive procedures, guide treatment decisions in stroke care, and support research into conditions ranging from dementia to traumatic brain injury.
This research builds on a technique called laser speckle contrast imaging, or LSCI, which has been widely used in biomedical research to image blood flow. When laser light illuminates tissue, the movement of red blood cells causes the resulting laser speckle pattern, a granular, shimmering image, to blur in proportion to how fast the cells are moving. By analyzing that blur, researchers can map blood flow across an entire field of view simultaneously, without touching the tissue or injecting dyes.
However, conventional LSCI provides only relative measurements. It can tell that flow increased or decreased, but not by exactly how much, or what the absolute blood flow is.
Simsi solves this problem by adding precise modulation to the laser illumination, varying light intensity in a sinusoidal pattern at a controlled frequency within each camera exposure. This seemingly simple addition, combined with a new imaging model, encodes information about fast blood flow dynamics into the speckle images, allowing researchers to make more quantitative, physically meaningful measurements without relying on high-speed cameras.
The result is a camera-based system that produces quantitative maps of rapid blood flow dynamics across a wide field of view without contacting the tissue.
“Blood flow can change over many timescales, but the optical fluctuations that reveal how fast blood is moving are often too fast for standard cameras to sample directly,” said Hengfa Lu, a postdoctoral fellow in Dunn’s Functional Optical Imaging Laboratory who led the development of the Simsi framework. “By intentionally modulating the illumination during the exposure and using a newly derived imaging model, we can recover fast blood flow dynamics that would otherwise be averaged out. That gives researchers a more quantitative way to study how tissue is functioning, from stroke recovery in the lab to, eventually, surgical decision-making.”
Dunn has been working on this research for 25 years, dating back to documenting the first use of laser speckle to image brain blood flow in 2001. He translated this technology to the operating room for the first time in 2010. In 2024, Dunn worked with UT’s Discovery to Impact commercialization hub to license his Speckleview surgical imaging platform to Austin-based medical device startup Dynamic Light.
Looking ahead, the team sees Simsi as part of a broader effort to make fast, quantitative blood flow imaging more accessible. By pairing engineered illumination with a physics-based imaging model, the approach enables standard cameras to capture rapid dynamics while maintaining long, light-efficient exposures. That could open new opportunities in stroke research, brain injury, surgery and other areas where blood flow is an early signal of tissue health.
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
The project was funded by the UT Austin Portugal Program and the National Institutes of Health. Other team members are Qingwei Fang of the Department of Biomedical Engineering; Jewel A. Ashbrook of the departments of Biomedical Engineering and Physics; Victoria Nemchek and Theresa A. Jones of the Department of Psychology; and Michela Fracassi of the Department of Neuroscience.